These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 6979443)

  • 81. Effects of antiarthritic compounds on sheep erythrocyte-induced delayed-type hypersensitivity.
    Schrier DJ
    J Immunopharmacol; 1985; 7(3):313-23. PubMed ID: 4056412
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Adjuvant polyarthritis. II. Suppression by tilorone.
    Chang YH
    J Pharmacol Exp Ther; 1977 Oct; 203(1):156-61. PubMed ID: 909049
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Interactions of aspirin, indomethacin and other drugs in adjuvant-induced arthritis in the rat.
    Van Arman CG; Nuss GW; Risley EA
    J Pharmacol Exp Ther; 1973 Nov; 187(2):400-14. PubMed ID: 4748556
    [No Abstract]   [Full Text] [Related]  

  • 84. [Increased proteolytic activity of cathepsin D in the skin of rats after administration of various anti-inflammatory drugs].
    Pałka JA; Galewska Z; Wróbel K
    Przegl Dermatol; 1990; 77(5):327-31. PubMed ID: 2270295
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The absence of antibodies to type II collagen in established adjuvant arthritis in rats.
    DeLustro F; Carlson RP; Datko LJ; DeLustro B; Lewis AJ
    Agents Actions; 1984 Jun; 14(5-6):673-9. PubMed ID: 6475663
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Initial arthritic lesions induced by immunization with type II collagen in Lewis rats.
    Takeshita M; Hinoue H; Furukawa O; Takata I
    Exp Anim; 1995 Jan; 44(1):63-6. PubMed ID: 7705481
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The effect of SM-8849 on experimental arthritis in mice.
    Nagai H; Takaoka Y; Kuwabara K; Kamada H; Kitagaki K
    Pharmacology; 1996 Jun; 52(6):377-86. PubMed ID: 8844788
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The effect of TRK-530 on experimental arthritis in mice.
    Takaoka Y; Nagai H; Mori H; Tanahashi M
    Biol Pharm Bull; 1997 Nov; 20(11):1147-50. PubMed ID: 9401721
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [The role of anti-type II collagen antibody in the pathogenesis of murine collagen-induced arthritis].
    Hirofuji T; Kakimoto K; Koga T; Saisho K; Sumiyoshi A
    Fukuoka Igaku Zasshi; 1986 Mar; 77(3):185-93. PubMed ID: 3721384
    [No Abstract]   [Full Text] [Related]  

  • 90. Studies on the effect of D-penicillamine on type II collagen-induced polyarthritis.
    Kerwar SS; Sloboda AE; Birnbaum JE; Oronsky AL
    J Rheumatol Suppl; 1981; 7():84-9. PubMed ID: 6939888
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Immunopharmacological studies of new 3-benzoyl-4-mercaptobutyric acids. Immunomodulating effects.
    Takeshita K; Fukazawa I; Futaki N; Kameo K; Tomisawa K; Otomo S; Aihara H
    Arzneimittelforschung; 1988 Apr; 38(4):537-42. PubMed ID: 3041971
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Nonsteroidal anti-inflammatory drugs.
    Weiner M
    Ration Drug Ther; 1971 Oct; 5(10):1-5. PubMed ID: 5096701
    [No Abstract]   [Full Text] [Related]  

  • 93. Humoral and cellular immunologic responses in collagen-induced arthritis in rats: their correlation with severity of arthritis.
    Carlson RP; Blazek EM; Datko LJ; Lewis AJ
    J Immunopharmacol; 1984; 6(4):379-88. PubMed ID: 6527009
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [The testing of long-term antirheumatics in animals].
    Bekemeier H; Hirschelmann R; Weber M
    Pharmazie; 1987 Oct; 42(10):680-6. PubMed ID: 2449699
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Activity of nonsteroid anti-inflammatory drugs in immunologically specific and nonspecific cellular responses.
    Kowalczyk-Bronisz SH; Gieldanowski J
    Arch Immunol Ther Exp (Warsz); 1976; 24(1):149-57. PubMed ID: 1083222
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [The role of neutrophils in the pathogenesis of rheumatoid arthritis and their changes as affected by anti-rheumatic agents].
    Malinovskaia EI
    Revmatologiia (Mosk); 1988; (2):63-8. PubMed ID: 3051279
    [No Abstract]   [Full Text] [Related]  

  • 97. RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease.
    Jahagirdar R; Attwell S; Marusic S; Bendele A; Shenoy N; McLure KG; Gilham D; Norek K; Hansen HC; Yu R; Tobin J; Wagner GS; Young PR; Wong NCW; Kulikowski E
    Mol Pharmacol; 2017 Dec; 92(6):694-706. PubMed ID: 28974538
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Preliminary research on the activity of anti-inflammatory drugs in arthritis induced b adjuvant in rats].
    Velo GP
    Boll Soc Ital Biol Sper; 1969 Jan; 45(1):39-41. PubMed ID: 5347982
    [No Abstract]   [Full Text] [Related]  

  • 99. Studies on type II collagen induced arthritis in mice.
    Paska W; McDonald KJ; Croft M
    Agents Actions; 1986 Jun; 18(3-4):413-20. PubMed ID: 3092598
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The effects of oral D-penicillamine treatment on experimental arthritis and the associated immune response in rabbits. II. The effects on cellular parameters.
    Hunneyball IM; Stewart GA; Stanworth DR
    Immunology; 1978 Jul; 35(1):159-66. PubMed ID: 680799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.